Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Income towards Parent Company (2018 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Income towards Parent Company for 15 consecutive years, with $44.8 million as the latest value for Q4 2025.

  • Quarterly Income towards Parent Company rose 244.06% to $44.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124.5 million through Dec 2025, up 500.32% year-over-year, with the annual reading at $124.5 million for FY2025, 3186.63% up from the prior year.
  • Income towards Parent Company hit $44.8 million in Q4 2025 for Ligand Pharmaceuticals, down from $117.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $117.3 million in Q3 2025 to a low of -$42.5 million in Q1 2025.
  • Historically, Income towards Parent Company has averaged $3.2 million across 5 years, with a median of -$3.8 million in 2021.
  • Biggest five-year swings in Income towards Parent Company: tumbled 136.03% in 2022 and later skyrocketed 244.06% in 2025.
  • Year by year, Income towards Parent Company stood at -$2.2 million in 2021, then crashed by 32.75% to -$3.0 million in 2022, then surged by 43.58% to -$1.7 million in 2023, then crashed by 1767.15% to -$31.1 million in 2024, then surged by 244.06% to $44.8 million in 2025.
  • Business Quant data shows Income towards Parent Company for LGNDZ at $44.8 million in Q4 2025, $117.3 million in Q3 2025, and $4.8 million in Q2 2025.